NASDAQ:KURA
Kura Oncology Stock News
$22.17
-0.81 (-3.52%)
At Close: May 17, 2024
Zacks Investment Research Downgrades Kura Oncology (NASDAQ:KURA) to Hold
07:26am, Wednesday, 29'th Apr 2020
Kura Oncology (NASDAQ:KURA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, �
6 Stocks To Watch: AMC, BLDR, CREX, KURA, NGL, RRGB
12:00am, Wednesday, 29'th Apr 2020
Stocks Analysis by Harry Boxer covering: MGM Resorts International, Fluor Corporation, Builders FirstSource Inc, Avadel Pharmaceuticals PLC. Read Harry Boxer's latest article on Investing.com
Why Kura Oncology Is Skyrocketing Today
07:09pm, Tuesday, 28'th Apr 2020
Shares of Kura Oncology (NASDAQ: KURA) -- a clinical-stage biopharmaceutical company that focuses on developing cancer treatments -- were up by 42.6% as of 1:49 p.m. EDT on Tuesday. The company did n
56 Stocks Moving In Tuesday's Mid-Day Session
04:27pm, Tuesday, 28'th Apr 2020
Gainers
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares jumped 68.6% to $19.40 after the company presented positive preclinical and initial clinical data for SNDX-5613, its...
Zacks Investment Research Upgrades Kura Oncology (NASDAQ:KURA) to "Buy"
08:44am, Tuesday, 28'th Apr 2020
Kura Oncology (NASDAQ:KURA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm currently has a $12.00
Analyzing Kura Oncology (NASDAQ:KURA) & Roche Holdings AG Basel (NASDAQ:RHHBY)
06:18am, Monday, 27'th Apr 2020
Roche Holdings AG Basel (OTCMKTS:RHHBY) and Kura Oncology (NASDAQ:KURA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of th
BRIEF-Kura Oncology On April 22, Co Entered Into A Second Amendment To Sublease With Araxes Pharma Llc
09:19pm, Friday, 24'th Apr 2020
Kura Oncology Inc:
Kura Oncology (NASDAQ:KURA) Stock Rating Upgraded by BidaskClub
07:42am, Friday, 24'th Apr 2020
Kura Oncology (NASDAQ:KURA) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday, BidAskClub reports. Several other equities research analysts als
Bank of America Corp DE Has $1.15 Million Stock Holdings in Kura Oncology Inc (NASDAQ:KURA)
09:08am, Thursday, 23'rd Apr 2020
Bank of America Corp DE decreased its stake in Kura Oncology Inc (NASDAQ:KURA) by 15.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Comm
Kura Sushi Returns $6 Million Paycheck Protection Loan. Will Other Restaurant Chains Follow?
11:16pm, Wednesday, 22'nd Apr 2020
The U.S. restaurant chain that is majority owned by a Japanese company said on Wednesday it would be returning the emergency government funding it received.
Bank of New York Mellon Corp Purchases 3,821 Shares of Kura Oncology Inc (NASDAQ:KURA)
09:50am, Wednesday, 22'nd Apr 2020
Bank of New York Mellon Corp grew its position in shares of Kura Oncology Inc (NASDAQ:KURA) by 2.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Com
Exane Derivatives Makes New Investment in Kura Oncology Inc (NASDAQ:KURA)
09:36am, Monday, 20'th Apr 2020
Exane Derivatives purchased a new position in Kura Oncology Inc (NASDAQ:KURA) during the 1st quarter, HoldingsChannel reports. The firm purchased 9,705 shares of the company’s stock, valued at appro
Kura Oncology Inc (NASDAQ:KURA) Stock Holdings Lifted by Bailard Inc.
11:26am, Saturday, 18'th Apr 2020
Bailard Inc. raised its stake in Kura Oncology Inc (NASDAQ:KURA) by 14.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 48,434 sha
Zacks Investment Research Lowers Kura Oncology (NASDAQ:KURA) to Hold
08:38am, Friday, 17'th Apr 2020
Kura Oncology (NASDAQ:KURA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports
Kura Oncology (NASDAQ:KURA) Upgraded to "Buy" at Zacks Investment Research
07:16am, Thursday, 16'th Apr 2020
Kura Oncology (NASDAQ:KURA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Zacks.com reports. The brokerag